Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab
已完结10由 达姆 发布于 2026/9/3 9:43:35
DOI:10.1097/hep.0000000000001444
作者:Heechul Nam, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Chang Wook Kim, Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Soon Kyu Lee, Jung Hyun K
文献类型:期刊论文
补充材料:只需要正文